Lorem ipsum
Collapse navigation.
Lorem ipsum
When Advil launched in the United States in 1984, it marked a turning point in pain relief management. With ibuprofen becoming the first new over-the-counter (OTC) pain-relief ingredient available to U.S. consumers in nearly three decades1, Advil introduced an ibuprofen-based option that would go on to reshape expectations around pain management.
From its rich scientific heritage to culturally resonant campaigns, Advil’s evolution reflects how iconic brands stay relevant – by understanding what people need and meeting them where they are.
At the heart of Advil is ibuprofen – a non-steroidal anti-inflammatory drug (NSAID) developed to relieve pain, caused by inflammation, at the source. Its transition from prescription to OTC in the 1980s, both in the U.S. and the UK, expanded access to an effective, trusted medicine and offered consumers a powerful new option for everyday pain management2. The launch tapped into changing attitudes around self-care, and Advil quickly became known for being a trusted, science-backed pain relief solution meeting a variety of needs and preferences.
“Advil has always been rooted in science and efficacy,” says Kathryn Swallow, OTC Category Head, Haleon. “What has made Advil such a trusted and loved brand for more than four decades is its ability to pair that scientific credibility with a deep understanding of how people experience pain - and to be there for consumers exactly when and where they need it.
Pain remains one of the most common everyday health concerns globally, around 90% of people experience pain yearly3, yet many instances go untreated. As expectations around self-care and convenience have evolved, so too has Advil’s approach - expanding beyond a single product into a broad portfolio designed to meet different needs, lifestyles and preferences.
At the turn of the millennium, Advil introduced Liqui-Gels - a format designed for faster absorption and easier swallowing. The Liqui-Gel quickly became one of the brand’s most recognisable products, reinforcing its position as a modern, strong solution for pain relief.
Today, the range spans tablets, capsules, topical formats, with solutions tailored to a variety of pain types including headaches, muscle aches, joint pain and cold and flu symptoms, and for different consumers, including children. More recently, products like Advil Dual Action4 in the U.S. have expanded the brand’s portfolio by combining two well-established ingredients (paracetamol (acetaminophen) and ibuprofen) in one product to help fight pain in two ways: using multimodal analgesia to block pain signals while targeting pain at the source, for long-lasting relief.
“For Advil, innovation is not only about formats or formulations, it’s about understanding how people experience pain today. Consumers increasingly expect healthcare brands to fit seamlessly into their lives,” says Swallow. “That means combining efficacy and science with accessibility, relevance and real-life insight – designing solutions for real life, powered by science”
At the heart of this cultural connection is Advil’s award winning “Big Little Emergencies” campaign. Designed to resonate with younger audiences, particularly Gen Z, it was built on insight that many people felt their pain was often misunderstood or dismissed.
Rather than focusing solely on symptoms, the campaign reframed pain through the lens of moments that matter, that consumers feared missing – first dates, big auditions, dream holidays and more. Each execution highlighted how conditions like tough migraines, back pain or period pain can disrupt emotionally significant experiences, validating their impact in a more human, relatable way.
As the campaign expanded globally, markets adapted it to reflect locally relevant moments - from a wedding proposal in Asia to a final cup match in Latin America. In doing so, it demonstrated how a global brand can remain culturally specific, while staying anchored in a consistent idea. In markets around the world, the campaign has resonated deeply with younger audiences, especially across social-first platforms.
“Today, consumers expect more from brands than functionality alone,” Swallow adds. “They want brands that understand them, reflect their experiences and show up authentically in culture. The trust consumers place in Advil stems from its ability to evolve alongside consumers while staying rooted in the science and trust that have defined the brand for more than four decades.”
4 Advil Dual Action is marketed under different names in different markets.
As excitement built around the major football moments of summer 2026, Advil in the U.S. brought its cultural perspective on pain into the game - encouraging a shift in how athletes and fans think about performance, recovery and pain management by promoting the importance of recognising and appropriately addressing pain rather than ignoring it. With “No Pain. More Gain,” a modern take on the traditional mantra, the brand challenged one of sport’s oldest beliefs.
Told through real-world moments and social storytelling, the campaign sits at the heart of global football culture – a brilliant example of how Advil continues to show up not just in moments of pain, but in everyday life.
Related
